OTC Markets Group Welcomes Bayer AG to OTCQX
OTC Markets Group has announced that Bayer AG, a major life science company, has qualified to trade on the OTCQX Best Market, upgrading from the Pink market. Bayer, which operates through three divisions – Pharmaceuticals, Consumer Health, and Crop Science, began trading on OTCQX under the symbols "BAYRY" and "BAYZF" on May 23, 2025.
The upgrade to OTCQX represents a significant step for Bayer in providing transparent trading for U.S. investors. Companies listed on OTCQX must meet high financial standards, follow best practice corporate governance, and demonstrate securities law compliance. The move allows Bayer to utilize its home market reporting to make information available to U.S. investors.
OTC Markets Group ha annunciato che Bayer AG, una grande azienda nel settore delle scienze della vita, si è qualificata per negoziare sul mercato OTCQX Best Market, passando dal mercato Pink. Bayer, che opera attraverso tre divisioni – Pharmaceuticals, Consumer Health e Crop Science, ha iniziato a negoziare su OTCQX con i simboli "BAYRY" e "BAYZF" il 23 maggio 2025.
Il passaggio a OTCQX rappresenta un passo importante per Bayer nel garantire una negoziazione trasparente agli investitori statunitensi. Le aziende quotate su OTCQX devono rispettare elevati standard finanziari, seguire le migliori pratiche di governance aziendale e dimostrare il rispetto delle normative sui titoli. Questa mossa permette a Bayer di utilizzare il reporting del suo mercato domestico per rendere le informazioni disponibili agli investitori negli Stati Uniti.
OTC Markets Group ha anunciado que Bayer AG, una importante empresa de ciencias de la vida, se ha calificado para cotizar en el OTCQX Best Market, ascendiendo desde el mercado Pink. Bayer, que opera a través de tres divisiones – Pharmaceuticals, Consumer Health y Crop Science, comenzó a cotizar en OTCQX bajo los símbolos "BAYRY" y "BAYZF" el 23 de mayo de 2025.
La mejora a OTCQX representa un paso significativo para Bayer en ofrecer una negociación transparente para los inversores estadounidenses. Las empresas listadas en OTCQX deben cumplir con altos estándares financieros, seguir las mejores prácticas de gobernanza corporativa y demostrar cumplimiento de las leyes de valores. Este movimiento permite a Bayer utilizar su reporte del mercado local para poner la información a disposición de los inversores en EE. UU.
OTC Markets Group는 주요 생명과학 기업인 Bayer AG가 OTCQX Best Market에서 거래 자격을 획득하여 Pink 시장에서 업그레이드되었음을 발표했습니다. Bayer는 Pharmaceuticals, Consumer Health, Crop Science의 세 부문을 통해 운영되며, 2025년 5월 23일부터 "BAYRY"와 "BAYZF"라는 심볼로 OTCQX에서 거래를 시작했습니다.
OTCQX로의 업그레이드는 미국 투자자들에게 투명한 거래를 제공하는 데 있어 Bayer에게 중요한 진전입니다. OTCQX에 상장된 기업은 높은 재무 기준을 충족하고, 우수한 기업 지배구조를 준수하며, 증권법 준수를 입증해야 합니다. 이번 조치는 Bayer가 본국 시장 보고를 활용하여 미국 투자자들에게 정보를 제공할 수 있게 합니다.
OTC Markets Group a annoncé que Bayer AG, une grande entreprise des sciences de la vie, s'est qualifiée pour être cotée sur le marché OTCQX Best Market, passant du marché Pink. Bayer, qui opère à travers trois divisions – Pharmaceuticals, Consumer Health et Crop Science, a commencé à être négociée sur OTCQX sous les symboles "BAYRY" et "BAYZF" le 23 mai 2025.
La montée en gamme vers OTCQX représente une étape importante pour Bayer afin d'offrir une négociation transparente aux investisseurs américains. Les entreprises cotées sur OTCQX doivent respecter des normes financières élevées, suivre les meilleures pratiques de gouvernance d'entreprise et démontrer leur conformité aux lois sur les valeurs mobilières. Cette démarche permet à Bayer d'utiliser ses rapports du marché domestique pour rendre les informations accessibles aux investisseurs américains.
OTC Markets Group hat bekannt gegeben, dass Bayer AG, ein führendes Unternehmen im Bereich Life Sciences, sich für den Handel am OTCQX Best Market qualifiziert hat und vom Pink Market aufgestiegen ist. Bayer, das in drei Geschäftsbereichen – Pharmaceuticals, Consumer Health und Crop Science – tätig ist, begann am 23. Mai 2025 unter den Symbolen "BAYRY" und "BAYZF" am OTCQX zu handeln.
Der Aufstieg zum OTCQX stellt einen bedeutenden Schritt für Bayer dar, um US-Investoren transparenten Handel zu bieten. Unternehmen, die am OTCQX gelistet sind, müssen hohe finanzielle Standards erfüllen, bewährte Corporate-Governance-Praktiken einhalten und die Einhaltung der Wertpapiergesetze nachweisen. Dieser Schritt ermöglicht es Bayer, seine Heimatmarkt-Berichterstattung zu nutzen, um US-Investoren Informationen bereitzustellen.
- Upgrade to OTCQX Best Market provides enhanced visibility and accessibility for U.S. investors
- Ability to use home market reporting streamlines compliance and disclosure requirements
- Access to Real-Time Level 2 quotes increases transparency for investors
- None.
NEW YORK, May 23, 2025 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Bayer AG (Frankfurt Stock Exchange: BAYN; OTCQX: BAYRY, BAYZF), a life science company with three divisions – Pharmaceuticals, Consumer Health and Crop Science, has qualified to trade on the OTCQX® Best Market. Bayer AG upgraded to OTCQX from the Pink® market.
Bayer AG begins trading today on OTCQX under the symbols “BAYRY” and “BAYZF.” U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the company on www.otcmarkets.com.
Upgrading to the OTCQX Market is an important step for companies seeking to provide transparent trading for their U.S. investors. For companies listed on a qualified international exchange, streamlined market standards enable them to utilize their home market reporting to make their information available in the U.S. To qualify for OTCQX, companies must meet high financial standards, follow best practice corporate governance and demonstrate compliance with applicable securities laws.
“We are thrilled to welcome Bayer to OTCQX,” said Jason Paltrowitz, OTC Markets EVP of Corporate Services. “This milestone highlights the continued interplay between the European capital markets and U.S. investors seeking new investment opportunities."
About Bayer
Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. In line with its mission, “Health for all, Hunger for none,” the company’s products and services are designed to help people and the planet thrive by supporting efforts to master the major challenges presented by a growing and aging global population. Bayer is committed to driving sustainable development and generating a positive impact with its businesses. At the same time, the Group aims to increase its earning power and create value through innovation and growth. The Bayer brand stands for trust, reliability and quality throughout the world. In fiscal 2024, the Group employed around 93,000 people and had sales of 46.6 billion euros. R&D expenses amounted to 6.2 billion euros. For more information, go to www.bayer.com.
About OTC Markets Group Inc.
OTC Markets Group Inc. (OTCQX: OTCM) operates regulated markets for trading 12,000 U.S. and international securities. Our data-driven disclosure standards form the foundation of our three public markets: OTCQX® Best Market, OTCQB® Venture Market, and Pink® Open Market.
Our OTC Link® Alternative Trading Systems (ATSs) provide critical market infrastructure that broker-dealers rely on to facilitate trading. Our innovative model offers companies more efficient access to the U.S. financial markets.
OTC Link ATS, OTC Link ECN, OTC Link NQB, and MOON ATSTM are each an SEC regulated ATS, operated by OTC Link LLC, a FINRA and SEC registered broker-dealer, member SIPC.
To learn more about how we create better informed and more efficient markets, visit www.otcmarkets.com.
Subscribe to the OTC Markets RSS Feed
Media Contact:
OTC Markets Group Inc., +1 (212) 896-4428, media@otcmarkets.com
FAQ
What does Bayer's upgrade to OTCQX mean for investors?
What are Bayer's new trading symbols on OTCQX?
What requirements did Bayer need to meet for OTCQX qualification?
What are the main divisions of Bayer AG?
